We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

GURE:NASDAQGulf Resources, Inc. Analysis

Data as of 2026-06-19 - not real-time

$3.85

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Technical outlook: GURE trades at $3.85, well below its 20‑day (4.26), 50‑day (4.31) and 200‑day (4.87) SMAs, with a bearish MACD histogram and a neutral‑to‑slightly‑oversold RSI at 45. Volume is decreasing and 30‑day volatility exceeds 100%, indicating a fragile price environment. Valuation signals are mixed: the price‑to‑book ratio of 0.05 and price‑to‑sales of 0.29 suggest deep discounting, while the DCF fair value of $89.3 implies extreme undervaluation, a gap likely driven by the company’s distressed fundamentals.
Fundamental and risk backdrop: The firm reports negative gross (‑28%) and operating margins, a trailing EPS of –$49.34 and a debt‑to‑equity of 7.5, flagging solvency concerns. Cash of $5.8 M is insufficient to cover $8.1 M debt, and free cash flow is strongly negative. A recent Nasdaq notice over a delayed quarterly filing adds regulatory risk, and the China‑centric operations heighten geographic exposure. Combined with a low beta (~0.1) but high volatility and thin trading, the overall risk profile is elevated.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • Bearish technical indicators (price below all SMAs, negative MACD)
  • Negative margins and high debt burden
  • Regulatory uncertainty from Nasdaq filing delay

Medium Term

1–3 years
Cautious
Model confidence: 6/10

Key Factors

  • Continued cash flow deficits and unsustainable leverage
  • High price volatility and decreasing trading volume
  • Lack of clear turnaround catalyst

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Potential for deep value if restructuring succeeds
  • Strategic position in bromine and crude salt markets
  • Uncertainty around future earnings and debt resolution

Key Metrics & Analysis

Financial Health

Revenue Growth303.40%
Profit Margin-286.76%
ROE-43.38%
ROA-4.60%
Debt/Equity7.50
P/B Ratio0.0
Op. Cash Flow$5.5M
Free Cash Flow$-12061764

Technical Analysis

TrendBearish
RSI45.2
Support$3.51
Resistance$5.40
MA 20$4.25
MA 50$4.31
MA 200$4.87
MACDBearish
VolumeDecreasing
Fear & Greed Index92.14

Valuation

Fair Value$89.31
GradeUndervalued
TypeValue

Risk Assessment

Beta0.11
Volatility107.10%
Sector RiskHigh
Reg. RiskHigh
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.